Journal of Cystic Fibrosis
Volume 5, Issue 2 , Pages 93-99, May 2006

Segregation—the perspectives of young patients and their parents

Royal Belfast Hospital for Sick Children, UK

Received 4 August 2005; received in revised form 24 November 2005; accepted 13 December 2005.

Abstract 

Background

Segregation is used increasingly to prevent cross infection, yet little is known about service users' views regarding segregation and its perceived impact. The aim of this study was to elicit patients and carers' views and to involve them in the process of introducing segregation in a paediatric CF centre.

Method

Open-ended questionnaires were posted to all parents (n=192) and to patients over 10 years (n=101). A content analysis identified common themes. Inter-rater agreement about themes was high (83%).

Results

Parents (91%) and children (92%) supported segregated treatment. Parents appeared to be aware of the positive and negative aspects of segregation, and to engage in a balancing act that led them to conclude that segregation was a ‘necessary evil’. Children appeared to be less analytical and were concerned mostly with boredom and isolation. Age, level of maturity, and hospital experience were perceived to be determinants of patient adaptation to segregation.

Conclusion

Segregation has considerable emotional, social, and practical implications for patients and families. Obtaining users' views increased our understanding of the psychosocial consequences of segregation and facilitated its implementation.

Keywords: Cystic fibrosis, Segregation, Hospital admission, Patient views, Carers views

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was presented in a poster and oral presentation at the 28th European Cystic Fibrosis Conference, Crete, Greece in June 2005 [1].

PII: S1569-1993(05)00164-5

doi:10.1016/j.jcf.2005.12.002

Journal of Cystic Fibrosis
Volume 5, Issue 2 , Pages 93-99, May 2006